2m 2m 2m 2m 2m 2m 2m
Galectin (GALT)
NASDAQ
$3.41+$0.03 (+1.04%)
Price as of Oct 22, 2026 7:30 PM EDT- $339.9MMarket Cap
- -30.94%1-Year Change
- BiotechnologyIndustry
Galectin (GALT)
$3.41+$0.03 (+1.04%)
GALT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.37 | ||
Change | -$0.06 (-1.75%) | ||
Open | $3.46 | ||
High | $3.51 | ||
Low | $3.19 | ||
Previous Close | $3.43 | ||
Volume | 292,836 | ||
30-Day Average Volume | 211,844 | ||
1-Week Change | -7.42% | ||
1-Month Change | -14.90% | ||
1-Year Change | -30.94% | ||
3-Year Change | 65.20% | ||
5-Year Change | 4.66% | ||
Fundamentals | |||
Shares Outstanding | 100.8M | ||
Total Assets | $14.8M | ||
Market Cap | $339.9M | ||
Enterprise Value | $326.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$9.1M | ||
Free Cash Flow | -$2.4M | ||
EBIT | -$9.1M | ||
EBITDA | -$9.1M | ||
Net Working Capital | -$137.0M | ||
EPS | -$0.14 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -2 | ||
P/E | -24 | ||
PEG | 0 | ||
Price/Free Cash Flow | -139 | ||
Price/Operating Cash Flow | -139 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 6 | ||
Last Split Date | 03/23/2012 | ||
Earnings & Revenue